186 related articles for article (PubMed ID: 27021417)
1. Gold nanoparticle surface functionalization: mixed monolayer versus hetero bifunctional peg linker.
Harrison E; Coulter JA; Dixon D
Nanomedicine (Lond); 2016 Apr; 11(7):851-65. PubMed ID: 27021417
[TBL] [Abstract][Full Text] [Related]
2. A comparison of gold nanoparticle surface co-functionalization approaches using Polyethylene Glycol (PEG) and the effect on stability, non-specific protein adsorption and internalization.
Harrison E; Nicol JR; Macias-Montero M; Burke GA; Coulter JA; Meenan BJ; Dixon D
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():710-8. PubMed ID: 26952476
[TBL] [Abstract][Full Text] [Related]
3. Stabilizing gold nanoparticle bioconjugates in physiological conditions by PEGylation.
Comenge J; Puntes VF
Methods Mol Biol; 2013; 1025():281-9. PubMed ID: 23918346
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticle surface functionalization: a necessary requirement in the development of novel nanotherapeutics.
Nicol JR; Dixon D; Coulter JA
Nanomedicine (Lond); 2015; 10(8):1315-26. PubMed ID: 25955125
[TBL] [Abstract][Full Text] [Related]
5. Gold nanoparticles prepared by laser ablation in aqueous biocompatible solutions: assessment of safety and biological identity for nanomedicine applications.
Correard F; Maximova K; Estève MA; Villard C; Roy M; Al-Kattan A; Sentis M; Gingras M; Kabashin AV; Braguer D
Int J Nanomedicine; 2014; 9():5415-30. PubMed ID: 25473280
[TBL] [Abstract][Full Text] [Related]
6. Orthogonal analysis of functional gold nanoparticles for biomedical applications.
Tsai DH; Lu YF; DelRio FW; Cho TJ; Guha S; Zachariah MR; Zhang F; Allen A; Hackley VA
Anal Bioanal Chem; 2015 Nov; 407(28):8411-22. PubMed ID: 26362156
[TBL] [Abstract][Full Text] [Related]
7. Effect of the spacer structure on the stability of gold nanoparticles functionalized with monodentate thiolated poly(ethylene glycol) ligands.
Schulz F; Vossmeyer T; Bastús NG; Weller H
Langmuir; 2013 Aug; 29(31):9897-908. PubMed ID: 23829571
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size.
Oh E; Delehanty JB; Sapsford KE; Susumu K; Goswami R; Blanco-Canosa JB; Dawson PE; Granek J; Shoff M; Zhang Q; Goering PL; Huston A; Medintz IL
ACS Nano; 2011 Aug; 5(8):6434-48. PubMed ID: 21774456
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle size-specific actin rearrangement and barrier dysfunction of endothelial cells.
Liu Y; Rogel N; Harada K; Jarett L; Maiorana CH; German GK; Mahler GJ; Doiron AL
Nanotoxicology; 2017 Sep; 11(7):846-856. PubMed ID: 28885066
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro toxicity and anti-inflammatory properties of gold nanoparticle bioconjugates to the vascular system.
Uchiyama MK; Deda DK; Rodrigues SF; Drewes CC; Bolonheis SM; Kiyohara PK; Toledo SP; Colli W; Araki K; Farsky SH
Toxicol Sci; 2014 Dec; 142(2):497-507. PubMed ID: 25260831
[TBL] [Abstract][Full Text] [Related]
11. Gold nanoparticles do not induce myotube cytotoxicity but increase the susceptibility to cell death.
Leite PE; Pereira MR; do Nascimento Santos CA; Campos AP; Esteves TM; Granjeiro JM
Toxicol In Vitro; 2015 Aug; 29(5):819-27. PubMed ID: 25790728
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric Assessment of Gold Nanoparticle Cytotoxicity in Cancerous and Healthy Cells: The Role of Size, Shape, and Surface Chemistry.
Bhamidipati M; Fabris L
Bioconjug Chem; 2017 Feb; 28(2):449-460. PubMed ID: 27992181
[TBL] [Abstract][Full Text] [Related]
13. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity.
Boisselier E; Astruc D
Chem Soc Rev; 2009 Jun; 38(6):1759-82. PubMed ID: 19587967
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and functionalization of gold nanoparticles for cancer imaging.
Craig GA; Allen PJ; Mason MD
Methods Mol Biol; 2010; 624():177-93. PubMed ID: 20217596
[TBL] [Abstract][Full Text] [Related]
15. Systematically probing the bottom-up synthesis of AuPAMAM conjugates for enhanced transfection efficiency.
Figueroa ER; Yan JS; Chamberlain-Simon NK; Lin AY; Foster AE; Drezek RA
J Nanobiotechnology; 2016 Mar; 14():24. PubMed ID: 27029613
[TBL] [Abstract][Full Text] [Related]
16. One-pot aqueous phase growth of biocompatible 15-130 nm gold nanoparticles stabilized with bidentate PEG.
Oh E; Susumu K; Jain V; Kim M; Huston A
J Colloid Interface Sci; 2012 Jun; 376(1):107-11. PubMed ID: 22480398
[TBL] [Abstract][Full Text] [Related]
17. Robust ligand shells for biological applications of gold nanoparticles.
Duchesne L; Gentili D; Comes-Franchini M; Fernig DG
Langmuir; 2008 Dec; 24(23):13572-80. PubMed ID: 18991409
[TBL] [Abstract][Full Text] [Related]
18. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer.
Chattopadhyay N; Cai Z; Pignol JP; Keller B; Lechtman E; Bendayan R; Reilly RM
Mol Pharm; 2010 Dec; 7(6):2194-206. PubMed ID: 20973534
[TBL] [Abstract][Full Text] [Related]
19. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands.
Huang X; Peng X; Wang Y; Wang Y; Shin DM; El-Sayed MA; Nie S
ACS Nano; 2010 Oct; 4(10):5887-96. PubMed ID: 20863096
[TBL] [Abstract][Full Text] [Related]
20. Synergetic approach for simple and rapid conjugation of gold nanoparticles with oligonucleotides.
Li J; Zhu B; Yao X; Zhang Y; Zhu Z; Tu S; Jia S; Liu R; Kang H; Yang CJ
ACS Appl Mater Interfaces; 2014 Oct; 6(19):16800-7. PubMed ID: 25188540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
